Breakthrough Pneumococcal Bacteremia in Patients Being Treated with Azithromycin and Clarithromycin
Open Access
- 1 October 2000
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 31 (4) , 1008-1011
- https://doi.org/10.1086/318157
Abstract
Streptococcus pneumoniae strains have exhibited decreasing susceptibility to penicillins and macrolides during the past several years. We reviewed the medical charts of all patients with pneumococcal bacteremia who were admitted to a university hospital over a period of 1 year, to identify failures of outpatient therapy. Of 41 patients admitted with pneumococcal bacteremia, 4 had previously taken either azithromycin or clarithromycin for 3–5 days. All 4 had pneumococcal strains that exhibited low-level resistance to macrolide antibiotics. Among pneumococci, low-level resistance to macrolides can lead to clinical failure, and resistance to macrolides should be considered during the selection of empiric therapy for patients with presumed pneumococcal infections.Keywords
This publication has 16 references indexed in Scilit:
- Prevalence of Macrolide Resistance Mechanisms in Streptococcus pneumoniae Isolates from a Multicenter Antibiotic Resistance Surveillance Study Conducted in the United States in 1994-1995Clinical Infectious Diseases, 1999
- Pneumococcal macrolide resistance—myth or reality?Journal of Antimicrobial Chemotherapy, 1999
- Prevalence of Antimicrobial Resistance Among Respiratory Tract Isolates ofStreptococcus pneumoniaein North America: 1997 Results from the SENTRY Antimicrobial Surveillance ProgramClinical Infectious Diseases, 1998
- Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory seasonDiagnostic Microbiology and Infectious Disease, 1997
- Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycinAntimicrobial Agents and Chemotherapy, 1997
- Novel mechanism of macrolide resistance in Streptococcus pneumoniaeDiagnostic Microbiology and Infectious Disease, 1996
- Risk of infection with hepatitis A, B or C, cytomegalovirus, varicella or measles among child care providersThe Pediatric Infectious Disease Journal, 1996
- PNEUMOCOCCAL MENINGITIS DURING THERAPY OF OTITIS MEDIA WITH CLARITHROMYCINThe Pediatric Infectious Disease Journal, 1995
- Medical Section pf the American Lung Association: Guidelines for the Initial Management of Adults with Community-acquired Pneumonia: Diagnosis, Assessment of Severity, and Initial Antimicrobial TherapyAmerican Review of Respiratory Disease, 1993
- New and Emerging Etiologies for Community-Acquired Pneumonia with Implications for TherapyMedicine, 1990